214 related articles for article (PubMed ID: 7912191)
1. The competitive NMDA receptor antagonist CGP 40116 protects against status epilepticus-induced neuronal damage.
Fujikawa DG; Daniels AH; Kim JS
Epilepsy Res; 1994 Mar; 17(3):207-19. PubMed ID: 7912191
[TBL] [Abstract][Full Text] [Related]
2. Neuroprotective effect of ketamine administered after status epilepticus onset.
Fujikawa DG
Epilepsia; 1995 Feb; 36(2):186-95. PubMed ID: 7821277
[TBL] [Abstract][Full Text] [Related]
3. Differential neuroprotective effects of the NMDA receptor-associated glycine site partial agonists 1-aminocyclopropanecarboxylic acid (ACPC) and D-cycloserine in lithium-pilocarpine status epilepticus.
Peterson SL; Purvis RS; Griffith JW
Neurotoxicology; 2004 Sep; 25(5):835-47. PubMed ID: 15288514
[TBL] [Abstract][Full Text] [Related]
4. Single versus combinatorial therapies in status epilepticus: Novel data from preclinical models.
Löscher W
Epilepsy Behav; 2015 Aug; 49():20-5. PubMed ID: 25819944
[TBL] [Abstract][Full Text] [Related]
5. Anticonvulsant and behavioral effects of two novel competitive N-methyl-D-aspartic acid receptor antagonists, CGP 37849 and CGP 39551, in the kindling model of epilepsy. Comparison with MK-801 and carbamazepine.
Löscher W; Hönack D
J Pharmacol Exp Ther; 1991 Feb; 256(2):432-40. PubMed ID: 1671593
[TBL] [Abstract][Full Text] [Related]
6. Competitive NMDA receptor antagonists enhance the antielectroshock activity of various antiepileptics.
Pietrasiewicz T; Czechowska G; Dziki M; Turski WA; Kleinrok Z; Czuczwar SJ
Eur J Pharmacol; 1993 Nov; 250(1):1-7. PubMed ID: 7907019
[TBL] [Abstract][Full Text] [Related]
7. A comparative analysis of the neuroprotective properties of competitive and uncompetitive N-methyl-D-aspartate receptor antagonists in vivo: implications for the process of excitotoxic degeneration and its therapy.
Massieu L; Thedinga KH; McVey M; Fagg GE
Neuroscience; 1993 Aug; 55(4):883-92. PubMed ID: 7694181
[TBL] [Abstract][Full Text] [Related]
8. Co-administration of subtherapeutic diazepam enhances neuroprotective effect of COX-2 inhibitor, NS-398, after lithium pilocarpine-induced status epilepticus.
Trandafir CC; Pouliot WA; Dudek FE; Ekstrand JJ
Neuroscience; 2015 Jan; 284():601-610. PubMed ID: 25453777
[TBL] [Abstract][Full Text] [Related]
9. A new derivative of valproic acid amide possesses a broad-spectrum antiseizure profile and unique activity against status epilepticus and organophosphate neuronal damage.
White HS; Alex AB; Pollock A; Hen N; Shekh-Ahmad T; Wilcox KS; McDonough JH; Stables JP; Kaufmann D; Yagen B; Bialer M
Epilepsia; 2012 Jan; 53(1):134-46. PubMed ID: 22150444
[TBL] [Abstract][Full Text] [Related]
10. Long-term pregabalin treatment protects basal cortices and delays the occurrence of spontaneous seizures in the lithium-pilocarpine model in the rat.
André V; Rigoulot MA; Koning E; Ferrandon A; Nehlig A
Epilepsia; 2003 Jul; 44(7):893-903. PubMed ID: 12823571
[TBL] [Abstract][Full Text] [Related]
11. Orphenadrine-induced convulsive status epilepticus in rats responds to the NMDA antagonist dizocilpine.
Rejdak K; Nieoczym D; Czuczwar M; Kiś J; Wlaź P; Turski WA
Pharmacol Rep; 2014 Jun; 66(3):399-403. PubMed ID: 24905515
[TBL] [Abstract][Full Text] [Related]
12. Pentylenetetrazole preconditioning attenuates severity of status epilepticus induced by lithium-pilocarpine in male rats: evaluation of opioid/NMDA receptors and nitric oxide pathway.
Eslami F; Shayan M; Amanlou A; Rahimi N; Dejban P; Dehpour AR
Pharmacol Rep; 2022 Aug; 74(4):602-613. PubMed ID: 35871445
[TBL] [Abstract][Full Text] [Related]
13. Anticonvulsant action of both NMDA and non-NMDA receptor antagonists against seizures induced by homocysteine in immature rats.
Folbergrová J
Exp Neurol; 1997 Jun; 145(2 Pt 1):442-50. PubMed ID: 9217080
[TBL] [Abstract][Full Text] [Related]
14. Non-NMDA but not NMDA blockade at deep prepiriform cortex protects against hippocampal cell death in status epilepticus.
Kawaguchi K; Simon RP
Brain Res; 1997 Apr; 753(1):152-6. PubMed ID: 9125442
[TBL] [Abstract][Full Text] [Related]
15. Memantine decreases neuronal degeneration in young rats submitted to LiCl-pilocarpine-induced status epilepticus.
Zenki KC; Kalinine E; Zimmer ER; Dos Santos TG; Mussulini BHM; Portela LVC; de Oliveira DL
Neurotoxicology; 2018 May; 66():45-52. PubMed ID: 29545205
[TBL] [Abstract][Full Text] [Related]
16. The new competitive NMDA receptor antagonist CGP 40116 inhibits pilocarpine-induced limbic motor seizures and unconditioned motor behaviour in the mouse.
Starr MS; Starr BS
Pharmacol Biochem Behav; 1994 Jan; 47(1):127-31. PubMed ID: 7906888
[TBL] [Abstract][Full Text] [Related]
17. Development of a rat pilocarpine model of seizure/status epilepticus that mimics chemical warfare nerve agent exposure.
Tetz LM; Rezk PE; Ratcliffe RH; Gordon RK; Steele KE; Nambiar MP
Toxicol Ind Health; 2006 Jul; 22(6):255-66. PubMed ID: 16924957
[TBL] [Abstract][Full Text] [Related]
18. Anticonvulsant activity of two orally active competitive N-methyl-D-aspartate antagonists, CGP 37849 and CGP 39551, against sound-induced seizures in DBA/2 mice and photically induced myoclonus in Papio papio.
Chapman AG; Graham JL; Patel S; Meldrum BS
Epilepsia; 1991; 32(4):578-87. PubMed ID: 1678345
[TBL] [Abstract][Full Text] [Related]
19. The effects of NMDA receptor antagonists at anticonvulsive doses on the performance of rats in the water maze task.
Ylinen A; Pitkänen M; Sirviö J; Hartikainen T; Sivenius J; Koivisto E; Riekkinen PJ
Eur J Pharmacol; 1995 Feb; 274(1-3):159-65. PubMed ID: 7768268
[TBL] [Abstract][Full Text] [Related]
20. Effects of the competitive NMDA receptor antagonist, CGP 37849, on anticonvulsant activity and adverse effects of valproate in amygdala-kindled rats.
Löscher W; Hönack D
Eur J Pharmacol; 1993 Apr; 234(2-3):237-45. PubMed ID: 8097722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
